Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117234) titled 'Research on the Construction and Clinical Application of an Intelligent Diagnosis Model for Clear Cell Renal Cell Carcinoma Based on Multi-modal Radiomics and Artificial Intelligence' on Jan. 21.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: JIN HUA MUNICIPALS CENTRAL HOSPITAL
Condition:
Clear cell carcinoma of kidney
Intervention:
Gold Standard:Pathology diagnosis results
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-21
Target Sample Size: Target condition:340;Difficult condition:0
Countries of Recruitment:
China
To know ...